VEGFA and Alzheimer disease: In one study that examined aMCI, a dose-dependent effect of VEGF-A was found in the AD trajectory, such that VEGF levels in participants with aMCI were significantly higher than participants with AD dementia and significantly lower than in participants classified as healthy controls (Huang et al. 2013).